QVAR® Redihaler™ (beclomethasone dipropionate HFA) – New formulation approval
August 7, 2017 – Teva announced the FDA approval of QVAR Redihaler (beclomethasone dipropionate HFA) for the maintenance treatment of asthma as prophylactic therapy in patients 4 years of age and older.
Download PDF
